Appello Pharmaceuticals
Latest round
- Series A
Last raised
- Jun 2018
Total raised
- $11M
Investors
- 2
About Appello Pharmaceuticals
Appello Pharmaceuticals develops therapies for neurological conditions, including Alzheimer's and Parkinson's disease. Founded by Craig Lindsley, the company is based in Nashville, US.Appello Pharmaceuticals specializes in innovative therapeutic solutions for neurological disorders. Their product pipeline includes drugs targeting diseases such as Alzheimer's, Parkinson's, and multiple sclerosis, with a focus on enhancing cognitive function and neuroprotection.Appello Pharmaceuticals generates revenue primarily through partnerships with healthcare providers and distributors. Their pharmaceutical products are delivered through direct sales agreements with hospitals and clinics, while they may also enter licensing agreements with larger pharmaceutical firms to broaden market reach. The company plans to expand its market presence in North America and Europe, while also exploring opportunities in emerging Asian markets. Additionally, they are focused on launching new products developed from recent advancements in their research, with specific timelines yet to be announced.
Who invested in Appello Pharmaceuticals
2 investors across 1 round
See all investors in Appello Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 28, 2018
Amount
$11M
Investors
Questions about Appello Pharmaceuticals
Who invested in Appello Pharmaceuticals?
Appello Pharmaceuticals has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Appello Pharmaceuticals raised?
Appello Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Appello Pharmaceuticals last raise money?
Appello Pharmaceuticals's most recent round on record is a Series A, in Jun 2018.
What does Appello Pharmaceuticals do?
Appello Pharmaceuticals develops therapies for neurological conditions, including Alzheimer's and Parkinson's disease.
Where is Appello Pharmaceuticals headquartered?
Appello Pharmaceuticals is headquartered in Nashville, US.
Which VCs invest in companies like Appello Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Appello Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Appello Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.